Supplemental Evidence and Data Request on Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review, 15707-15709 [2017-06232]
Download as PDF
Federal Register / Vol. 82, No. 60 / Thursday, March 30, 2017 / Notices
joint service for the transportation of
containerized cargo in the trade between
the United States and all countries
worldwide, and to engage in cooperative
working arrangements in preparation for
the operation of the joint service.
By Order of the Federal Maritime
Commission.
Dated: March 27, 2017.
Rachel E. Dickon,
Assistant Secretary.
Supplemental Evidence and Data
Request on Physiologic Predictors of
the Need for Trauma Center Care: A
Systematic Review
FEDERAL RESERVE SYSTEM
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for Supplemental
Evidence and Data Submissions.
AGENCY:
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956, and all other applicable
statutes and regulations to become a
bank holding company and/or to
acquire the assets or the ownership of,
control of, or the power to vote shares
of a bank or bank holding company and
all of the banks and nonbanking
companies owned by the bank holding
company, including the companies
listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than April 25, 2017.
A. Federal Reserve Bank of Richmond
(Adam M. Drimer, Assistant Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261–4528.
Comments can also be sent
electronically to
Comments.applications@rich.frb.org:
1. Old Line Bancshares, Inc., Bowie,
Maryland; to acquire 100 percent of the
voting securities of DCB Bancshares,
Inc., Damascus, Maryland, and thereby
indirectly acquire Damascus
Community Bank, Damascus, Maryland.
Jkt 241001
BILLING CODE 6210–01–P
Agency for Healthcare Research and
Quality
BILLING CODE 6731–AA–P
19:09 Mar 29, 2017
[FR Doc. 2017–06279 Filed 3–29–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–06265 Filed 3–29–17; 8:45 am]
VerDate Sep<11>2014
Board of Governors of the Federal Reserve
System, March 27, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Physiologic Predictors of the Need for
Trauma Center Care: A Systematic
Review, which is currently being
conducted by the AHRQ’s Evidencebased Practice Centers (EPC) Program.
Access to published and unpublished
pertinent scientific information will
improve the quality of this review.
DATES: Submission Deadline on or
before May 1, 2017.
ADDRESSES:
Email submissions: SEADS@epcsrc.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator,PO Box
69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW., U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SEADS@epcsrc.org.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality (AHRQ) has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Physiologic Predictors of
the Need for Trauma Center Care: A
Systematic Review. AHRQ is conducting
this systematic review pursuant to
SUMMARY:
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
15707
Section 902(a) of the Public Health
Service Act, 42 U.S.C. 299a(a).
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Physiologic Predictors of
the Need for Trauma Center Care: A
Systematic Review, including those that
describe adverse events. The entire
research protocol, including the key
questions, is also available online at:
https://www.effectivehealthcare.
ahrq.gov/index.cfm/search-for-guidesreviews-and-reports/?pageaction=
displayproduct&productid=2435
This is to notify the public that the
EPC Program would find the following
information on Physiologic Predictors of
the Need for Trauma Center Care: A
Systematic Review helpful:
D A list of completed studies that your
organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov,
please provide a summary, including
the following elements: Study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including a study number, the
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, and primary and secondary
outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this indication and an
index outlining the relevant information
in each submitted file.
Your contribution will be very
beneficial to the EPC Program. The
contents of all submissions will be made
available to the public upon request so
materials submitted must be publicly
available or able to be made public.
Materials that are considered
E:\FR\FM\30MRN1.SGM
30MRN1
15708
Federal Register / Vol. 82, No. 60 / Thursday, March 30, 2017 / Notices
confidential; marketing materials; study
types not included in the review; or
information on indications not included
in the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program Web site and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://www.effectivehealthcare.ahrq.
gov/index.cfm/join-the-email-list1/.
The systematic review will answer the
following questions. This information is
provided as background. AHRQ is not
requesting that the public provide
answers to these questions.
The Key Questions
Key Question 1
For patients with known or suspected
trauma who are treated out-of-hospital
by Emergency Medical System (EMS)
personnel, what is the predictive utility
of measures of circulatory compromise
(e.g., systolic blood pressure, mean
arterial pressure, heart rate, heart rate
complexity/variability) or derivative
measures (e.g., the shock index) for
predicting serious injury requiring
transport to the highest level trauma
center available?
I. How does the predictive utility of
the studied measures of circulatory
compromise vary across age groups (e.g.,
children or the elderly)? Specifically,
what age ranges and values for the
different age ranges are supported by the
evidence?
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Key Question 2
For patients with known or suspected
trauma who are treated out-of-hospital
by EMS personnel, what is the
predictive utility of measures of
respiratory compromise, (e.g.,
ventilatory support, respiration rate,
tissue O2 saturation, respiratory effort,
measures of acidemia such as end-tidal
CO2, lactate, or base deficit) for
predicting serious injury requiring
transport to the highest level trauma
center available?
I. How does the predictive utility of
the studied measures of respiratory
compromise vary across age groups (e.g.,
children or the elderly)? Specifically,
what age ranges and values for the
different age ranges are supported by the
evidence?
Key Question 3
For patients with known or suspected
trauma who are treated out of the
VerDate Sep<11>2014
19:09 Mar 29, 2017
Jkt 241001
hospital by EMS personnel, what is the
predictive utility for combinations of
measures of respiratory and circulatory
compromise together with or without
measures of altered levels of
consciousness (as defined by Glasgow
coma scale or its components), for
predicting serious injury requiring
transport to the highest level trauma
center available?
I. How does the predictive utility of
combinations of measures vary across
age groups (e.g., children or the
elderly)? Specifically, what age ranges
and values for the different age ranges
are supported by the evidence?
Using the PICOTS (Populations,
Interventions, Comparators, Outcomes,
Timing, Settings) framework and a
graphical analytic framework required
adapting these tools as they were
designed for and usually used for
intervention studies. Our approach is
informed by guidance related to
frameworks in the Methods Guide for
Systematic Reviews of Diagnostic Tests
in addition to the Methods Guide for
Effectiveness and Comparative
Effectiveness Reviews. We have
included the standard PICOTS terms,
but added detail to explain how we are
using them for this review and we have
added a legend and text to the graphical
framework.
PICOTS (Populations, Interventions,
Comparators, Outcomes, Timing,
Settings)
Population(s)
Population refers to the patients who
are the subjects in the studies to be
included.
Include: Studies of patients of any age
with known or suspected trauma who
require assessment of physiologic
compromise by EMS out of the hospital.
Exclude: Studies of patients with
nontrauma conditions or illnesses,
patients with burns or chemical
exposures, healthy people, and animal
studies. Studies of patients in which
other assessments are used (e.g., type of
injury) or in which the patient
population is limited to a subgroup of
patients defined as seriously injured.
• Studies in which the patient
population is a priori restricted to
patients with serious traumatic injuries.
• Studies in which all patients have
injuries that can be assessed or would
be defined as serious based on direct
observation (e.g., an amputation).
Interventions (Physiologic Measures)
The intervention is usually the
treatment or health service of interest
that is being evaluated in terms of its
impact on the population. In this review
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
the physiologic measures are what are
evaluated. This review will include any
measure of circulatory or respiratory
compromise or combination measures.
Examples are provided for each Key
Question; however, additional measures
may be identified by the search.
Include:
I. Key Question 1: Physiologic
measures of circulatory compromise,
including but not limited to systolic
blood pressure, mean arterial pressure,
heart rate, heart rate complexity/
variability, or derivative measures such
as the shock index.
II. Key Question 2: Physiologic
measures of respiratory compromise or
effort, including but not limited to
respiration rate, tissue O2 saturation,
respiratory effort, measure of acidemia
(e.g., end-tidal CO2, lactate, base
deficit), or advanced out-of-hospital
airway intervention.
III. Key Question 3: Combinations of
measures of respiratory and circulatory
compromise with or without measures
of altered levels of consciousness (as
defined by Glasgow coma scale or its
components).
IV. All Key Questions: Additional
measures may be identified during the
search and included based on input
from clinical experts. Studies of newer
devices that provide these or other
measurements will be included if
available and relevant.
In all cases measurement can be for a
single point in time, change over time,
or can be trends in the measure
evaluated by a person or technology.
Exclude: Clinical assessment or
indicator of health status that is not a
separate indicator or a combination
indicator including a measure of
circulatory or respiratory compromise
(e.g., temperature, consciousness, eye
tracking, musculoskeletal soundness,
balance, blood glucose, orientation).
Comparisons and Outcomes
As this is not a review of intervention
studies, the structure of the questions
for the review as well as the questions
posed by included studies are different.
The Key Questions address how well
measures of physiologic compromise
identify trauma patients likely to have a
serious injury requiring high-level
trauma care.
We include two types of evaluations
of measures: (1) Studies of how well
single measures predict severe injury;
and (2) studies that compare the
performance of two or more measures
directly (head-to-head studies).
The end points or ‘‘outcomes’’ of
interest are the predictive utility of the
measures. We include three different
approaches to assessing predictive
E:\FR\FM\30MRN1.SGM
30MRN1
Federal Register / Vol. 82, No. 60 / Thursday, March 30, 2017 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
utility: (1) Adjusted risk estimates (e.g.,
odds ratio, relative risk, hazards ratio);
(2) discrimination (e.g., area under the
receiver operating characteristic curve
[AUROC]); and (3) measures of
diagnostic accuracy (e.g., sensitivity,
specificity, positive predictive values,
and negative predictive values).
The predictive utility is defined in
terms of the physiologic measure’s
ability to identify patients who have
severe injury. Defining and
operationalizing what ‘‘severe injury’’
means is challenging for several reasons.
Whether a patient had a serious injury
at the time of field triage cannot be
determined conclusively and we expect
that clinical outcomes (e.g., death or
disability) are affected by out-of-hospital
and in-hospital treatment (i.e., a person
can have a serious injury and recover).
For this reason, we accept several
indicators that a patient was seriously
injured. These include outcomes, such
as death, whether the patient required
treatments and interventions used for
serious injury, or whether the injury is
rated as severe using accepted rating
scales. It is possible the review will
identify additional indicators that a
patient had a severe injury; however the
following list includes those that have
been used in prior research.
Indicators of Serious Injury
I. In-hospital mortality.
II. Resource use/intervention
standards or lists.
a. Published Consensus-Based
Criterion Standard—This list defines
need for trauma center care as any one
of the following 10 specific indicators:
Major surgery, advanced airway, blood
products, admission for spinal cord
injury, thoracotomy, pericardiocentesis,
cesarean delivery, intracranial pressure
monitoring, interventional radiology,
and in-hospital death.
b. Need For Life-Saving
Interventions—Lists used by the U.S.
military that include angioembolization,
blood transfusion, cardiopulmonary
resuscitation, chest tube, intubation,
needle decompression, surgical
cricothyrotomy or thoracotomy,
pericardiocentesis, angiography with
embolization, angiography without and
surgical intervention.
c. Major Surgery—Not including
orthopedic surgery.
d. Ratings of Injury Severity—Injury
Severity Score (ISS) >15, as this is a
commonly used threshold for high risk
patients, but other cut-offs will be
considered if used in included studies.
The ISS score is based on an assessment
that divides the body into nine regions,
classifies the level of injury in each of
the three most severely injured regions
VerDate Sep<11>2014
19:09 Mar 29, 2017
Jkt 241001
15709
on a scale of 1 to 6, squares these values,
and adds them together.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Timing
Centers for Disease Control and
Prevention
Physiological measures upon the
arrival of EMS personnel to the scene of
injury, during treatment in the field, and
during transport (referred to as out-ofhospital or in the field). Studies with
measures taken upon arrival at an
emergency department will be
considered. Details about timing of
measurement will be recorded in data
abstraction if they are reported.
Settings
Include:
I. Studies measuring physiologic
compromise in the field/out of
hospital
II. Studies of initial ED measurement as
indirect evidence only if out of
hospital evidence is not available
and the measure is deemed
clinically relevant
III. Studies conducted in civilian or
military settings
Exclude:
Study Designs
Include:
I. Any study that assesses the predictive
utility of included measures either
individually or that compares two
or more measures. Designs may
include trials and prospective and
retrospective observational studies
a. Systematic reviews
Exclude:
I. Nonsystematic reviews,
commentaries, and letters
II. Descriptions of the properties or
performance of measures that do
not include predictive utility
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–06232 Filed 3–29–17; 8:45 am]
BILLING CODE 4160–90–P
Frm 00025
Draft Current Intelligence Bulletin: The
Occupational Exposure Banding
Process: Guidance for the Evaluation
of Chemical Hazards; Notice of Public
Meeting; Request for Comments
Correction
In notice document 2017–5115,
beginning on page 13809, in the issue of
Wednesday, March 15, 2017, make the
following correction:
On page 13809, in the third column,
in the second line of the DATES
paragraph, ‘‘Tuesday, May 23, 2016’’
should read, ‘‘Tuesday, May 23, 2017.’’
[FR Doc. C1–2017–05115 Filed 3–29–17; 8:45 am]
BILLING CODE 1301–00–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
I. Inpatient, clinic, or emergency
department (ED)
II. Studies conducted in developing
countries with out-of-hospital care
systems that differ from those in the
United States
PO 00000
[CDC–2017–0028, Docket Number NIOSH–
290]
Fmt 4703
Sfmt 4703
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: April 24, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710 B
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Kimberly Lynette Houston,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS,
6710B Rockledge Drive, Bethesda, Maryland
E:\FR\FM\30MRN1.SGM
30MRN1
Agencies
[Federal Register Volume 82, Number 60 (Thursday, March 30, 2017)]
[Notices]
[Pages 15707-15709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06232]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Physiologic Predictors
of the Need for Trauma Center Care: A Systematic Review
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for Supplemental Evidence and Data Submissions.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review of Physiologic
Predictors of the Need for Trauma Center Care: A Systematic Review,
which is currently being conducted by the AHRQ's Evidence-based
Practice Centers (EPC) Program. Access to published and unpublished
pertinent scientific information will improve the quality of this
review.
DATES: Submission Deadline on or before May 1, 2017.
ADDRESSES:
Email submissions: src.org">SEADS@epc-src.org.
Print submissions:
Mailing Address: Portland VA Research Foundation, Scientific
Resource Center, ATTN: Scientific Information Packet Coordinator,PO Box
69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.): Portland VA Research
Foundation, Scientific Resource Center, ATTN: Scientific Information
Packet Coordinator, 3710 SW., U.S. Veterans Hospital Road, Mail Code:
R&D 71, Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT: Ryan McKenna, Telephone: 503-220-8262
ext. 51723 or Email: src.org">SEADS@epc-src.org.
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality (AHRQ) has commissioned the Evidence-based Practice Centers
(EPC) Program to complete a review of the evidence for Physiologic
Predictors of the Need for Trauma Center Care: A Systematic Review.
AHRQ is conducting this systematic review pursuant to Section 902(a) of
the Public Health Service Act, 42 U.S.C. 299a(a).
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Physiologic Predictors of the Need for Trauma Center
Care: A Systematic Review, including those that describe adverse
events. The entire research protocol, including the key questions, is
also available online at: https://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=2435
This is to notify the public that the EPC Program would find the
following information on Physiologic Predictors of the Need for Trauma
Center Care: A Systematic Review helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this indication. In the list, please indicate whether
results are available on ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, please provide a summary, including the following
elements: Study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including a study number, the study period,
design, methodology, indication and diagnosis, proper use instructions,
inclusion and exclusion criteria, and primary and secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this indication and an index outlining the relevant information in each
submitted file.
Your contribution will be very beneficial to the EPC Program. The
contents of all submissions will be made available to the public upon
request so materials submitted must be publicly available or able to be
made public. Materials that are considered
[[Page 15708]]
confidential; marketing materials; study types not included in the
review; or information on indications not included in the review cannot
be used by the EPC Program. This is a voluntary request for
information, and all costs for complying with this request must be
borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program Web
site and available for public comment for a period of 4 weeks. If you
would like to be notified when the draft is posted, please sign up for
the email list at: https://www.effectivehealthcare.ahrq.gov/index.cfm/join-the-email-list1/.
The systematic review will answer the following questions. This
information is provided as background. AHRQ is not requesting that the
public provide answers to these questions.
The Key Questions
Key Question 1
For patients with known or suspected trauma who are treated out-of-
hospital by Emergency Medical System (EMS) personnel, what is the
predictive utility of measures of circulatory compromise (e.g.,
systolic blood pressure, mean arterial pressure, heart rate, heart rate
complexity/variability) or derivative measures (e.g., the shock index)
for predicting serious injury requiring transport to the highest level
trauma center available?
I. How does the predictive utility of the studied measures of
circulatory compromise vary across age groups (e.g., children or the
elderly)? Specifically, what age ranges and values for the different
age ranges are supported by the evidence?
Key Question 2
For patients with known or suspected trauma who are treated out-of-
hospital by EMS personnel, what is the predictive utility of measures
of respiratory compromise, (e.g., ventilatory support, respiration
rate, tissue O2 saturation, respiratory effort, measures of acidemia
such as end-tidal CO2, lactate, or base deficit) for predicting serious
injury requiring transport to the highest level trauma center
available?
I. How does the predictive utility of the studied measures of
respiratory compromise vary across age groups (e.g., children or the
elderly)? Specifically, what age ranges and values for the different
age ranges are supported by the evidence?
Key Question 3
For patients with known or suspected trauma who are treated out of
the hospital by EMS personnel, what is the predictive utility for
combinations of measures of respiratory and circulatory compromise
together with or without measures of altered levels of consciousness
(as defined by Glasgow coma scale or its components), for predicting
serious injury requiring transport to the highest level trauma center
available?
I. How does the predictive utility of combinations of measures vary
across age groups (e.g., children or the elderly)? Specifically, what
age ranges and values for the different age ranges are supported by the
evidence?
Using the PICOTS (Populations, Interventions, Comparators,
Outcomes, Timing, Settings) framework and a graphical analytic
framework required adapting these tools as they were designed for and
usually used for intervention studies. Our approach is informed by
guidance related to frameworks in the Methods Guide for Systematic
Reviews of Diagnostic Tests in addition to the Methods Guide for
Effectiveness and Comparative Effectiveness Reviews. We have included
the standard PICOTS terms, but added detail to explain how we are using
them for this review and we have added a legend and text to the
graphical framework.
PICOTS (Populations, Interventions, Comparators, Outcomes, Timing,
Settings)
Population(s)
Population refers to the patients who are the subjects in the
studies to be included.
Include: Studies of patients of any age with known or suspected
trauma who require assessment of physiologic compromise by EMS out of
the hospital.
Exclude: Studies of patients with nontrauma conditions or
illnesses, patients with burns or chemical exposures, healthy people,
and animal studies. Studies of patients in which other assessments are
used (e.g., type of injury) or in which the patient population is
limited to a subgroup of patients defined as seriously injured.
Studies in which the patient population is a priori
restricted to patients with serious traumatic injuries.
Studies in which all patients have injuries that can be
assessed or would be defined as serious based on direct observation
(e.g., an amputation).
Interventions (Physiologic Measures)
The intervention is usually the treatment or health service of
interest that is being evaluated in terms of its impact on the
population. In this review the physiologic measures are what are
evaluated. This review will include any measure of circulatory or
respiratory compromise or combination measures. Examples are provided
for each Key Question; however, additional measures may be identified
by the search.
Include:
I. Key Question 1: Physiologic measures of circulatory compromise,
including but not limited to systolic blood pressure, mean arterial
pressure, heart rate, heart rate complexity/variability, or derivative
measures such as the shock index.
II. Key Question 2: Physiologic measures of respiratory compromise
or effort, including but not limited to respiration rate, tissue O2
saturation, respiratory effort, measure of acidemia (e.g., end-tidal
CO2, lactate, base deficit), or advanced out-of-hospital airway
intervention.
III. Key Question 3: Combinations of measures of respiratory and
circulatory compromise with or without measures of altered levels of
consciousness (as defined by Glasgow coma scale or its components).
IV. All Key Questions: Additional measures may be identified during
the search and included based on input from clinical experts. Studies
of newer devices that provide these or other measurements will be
included if available and relevant.
In all cases measurement can be for a single point in time, change
over time, or can be trends in the measure evaluated by a person or
technology.
Exclude: Clinical assessment or indicator of health status that is
not a separate indicator or a combination indicator including a measure
of circulatory or respiratory compromise (e.g., temperature,
consciousness, eye tracking, musculoskeletal soundness, balance, blood
glucose, orientation).
Comparisons and Outcomes
As this is not a review of intervention studies, the structure of
the questions for the review as well as the questions posed by included
studies are different. The Key Questions address how well measures of
physiologic compromise identify trauma patients likely to have a
serious injury requiring high-level trauma care.
We include two types of evaluations of measures: (1) Studies of how
well single measures predict severe injury; and (2) studies that
compare the performance of two or more measures directly (head-to-head
studies).
The end points or ``outcomes'' of interest are the predictive
utility of the measures. We include three different approaches to
assessing predictive
[[Page 15709]]
utility: (1) Adjusted risk estimates (e.g., odds ratio, relative risk,
hazards ratio); (2) discrimination (e.g., area under the receiver
operating characteristic curve [AUROC]); and (3) measures of diagnostic
accuracy (e.g., sensitivity, specificity, positive predictive values,
and negative predictive values).
The predictive utility is defined in terms of the physiologic
measure's ability to identify patients who have severe injury. Defining
and operationalizing what ``severe injury'' means is challenging for
several reasons. Whether a patient had a serious injury at the time of
field triage cannot be determined conclusively and we expect that
clinical outcomes (e.g., death or disability) are affected by out-of-
hospital and in-hospital treatment (i.e., a person can have a serious
injury and recover). For this reason, we accept several indicators that
a patient was seriously injured. These include outcomes, such as death,
whether the patient required treatments and interventions used for
serious injury, or whether the injury is rated as severe using accepted
rating scales. It is possible the review will identify additional
indicators that a patient had a severe injury; however the following
list includes those that have been used in prior research.
Indicators of Serious Injury
I. In-hospital mortality.
II. Resource use/intervention standards or lists.
a. Published Consensus-Based Criterion Standard--This list defines
need for trauma center care as any one of the following 10 specific
indicators: Major surgery, advanced airway, blood products, admission
for spinal cord injury, thoracotomy, pericardiocentesis, cesarean
delivery, intracranial pressure monitoring, interventional radiology,
and in-hospital death.
b. Need For Life-Saving Interventions--Lists used by the U.S.
military that include angioembolization, blood transfusion,
cardiopulmonary resuscitation, chest tube, intubation, needle
decompression, surgical cricothyrotomy or thoracotomy,
pericardiocentesis, angiography with embolization, angiography without
and surgical intervention.
c. Major Surgery--Not including orthopedic surgery.
d. Ratings of Injury Severity--Injury Severity Score (ISS) >15, as
this is a commonly used threshold for high risk patients, but other
cut-offs will be considered if used in included studies. The ISS score
is based on an assessment that divides the body into nine regions,
classifies the level of injury in each of the three most severely
injured regions on a scale of 1 to 6, squares these values, and adds
them together.
Timing
Physiological measures upon the arrival of EMS personnel to the
scene of injury, during treatment in the field, and during transport
(referred to as out-of-hospital or in the field). Studies with measures
taken upon arrival at an emergency department will be considered.
Details about timing of measurement will be recorded in data
abstraction if they are reported.
Settings
Include:
I. Studies measuring physiologic compromise in the field/out of
hospital
II. Studies of initial ED measurement as indirect evidence only if out
of hospital evidence is not available and the measure is deemed
clinically relevant
III. Studies conducted in civilian or military settings
Exclude:
I. Inpatient, clinic, or emergency department (ED)
II. Studies conducted in developing countries with out-of-hospital care
systems that differ from those in the United States
Study Designs
Include:
I. Any study that assesses the predictive utility of included measures
either individually or that compares two or more measures. Designs may
include trials and prospective and retrospective observational studies
a. Systematic reviews
Exclude:
I. Nonsystematic reviews, commentaries, and letters
II. Descriptions of the properties or performance of measures that do
not include predictive utility
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-06232 Filed 3-29-17; 8:45 am]
BILLING CODE 4160-90-P